16 articles for S Crosignani
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
17
Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists.

TBA
57
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids.

TBA
122
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.

Merck Serono
45
Discovery of a novel series of CXCR3 antagonists.

Merck Serono
53
Discovery of a novel series of potent S1P1 agonists.

Merck Serono
33
Discovery of a novel series of selective macrocyclic PKCTheta inhibitors.

Galderma SA
42
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i).

Merck
33
Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.

Iteos Therapeutics
61
Compounds and compositions for inhibiting the activity of SHP2

Novartis
38
Inhibitors of the renal outer medullary potassium channel

Merck Sharp & Dohme
20
S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use

Merck Sharp & Dohme
3
Evidence of ternary complex formation in Trypanosoma cruzi trans-sialidase catalysis.

Universidade Federal Do Rio De Janeiro
166
PDE 10a inhibitors for the treatment of type II diabetes

Janssen Pharmaceutica
6
Development of hydroxylated naphthylchalcones as polyphenol oxidase inhibitors: Synthesis, biochemistry and molecular docking studies.

University of Technology Sydney
1
[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.

Merck Research Laboratories
50
The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.

Merck Research Laboratories